Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer

Elena Castro, Chee Goh, David Olmos, Ed Saunders, Daniel Leongamornlert, Malgorzata Tymrakiewicz, Nadiya Mahmud, Tokhir Dadaev, Koveela Govindasami, Michelle Guy, Emma Sawyer, Rosemary Wilkinson, Audrey Ardern-Jones, Steve Ellis, Debra Frost, Susan Peock, D Gareth Evans, Marc Tischkowitz, Trevor Cole, Rosemarie DavidsonDiana Eccles, Carole Brewer, Fiona Douglas, Mary E Porteous, Alan Donaldson, Huw Dorkins, Louise Izatt, Jackie Cook, Shirley Hodgson, M John Kennedy, Lucy E Side, Jacqueline Eason, Alex Murray, Antonis C Antoniou, Douglas F Easton, Zsofia Kote-Jarai, Rosalind Eeles

Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029, Madrid, Spain.

Research output: Contribution to journal › Article › peer-review

647 Citations (Scopus)

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer

Fingerprint

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology